[HTML][HTML] Inhibitory immune checkpoint receptors and ligands as prognostic biomarkers in COVID-19 patients

MA Al-Mterin, A Alsalman, E Elkord - Frontiers in immunology, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2. During T-cell activation,
the immune system uses different checkpoint pathways to maintain co-inhibitory and co …

COVID-19 infection: a possible induction factor for development of autoimmune diseases?

N Saeedi, NSF Gohari, AAM Ghalibaf, A Dehghan… - Immunologic …, 2023 - Springer
Following the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection, the importance of investigation of the pathogenesis and immunological …

Immunological interactions in helminths‐SARS CoV‐2 coinfection: Could old enemy be a friend today?

M Alrouji, HM Al‐Kuraishy, AI Al‐Gareeb… - Parasite …, 2023 - Wiley Online Library
Helminths are metazoan parasites affecting about one third of the worldwide population.
Chronic helminth infections (CHIs) confer immunological tolerance to harmless and self …

[HTML][HTML] Immune signature of covid-19: In-depth reasons and consequences of the cytokine storm

P Niedźwiedzka-Rystwej, A Majchrzak… - International Journal of …, 2022 - mdpi.com
In the beginning of the third year of the fight against COVID-19, the virus remains at least still
one step ahead in the pandemic “war”. The key reasons are evolving lineages and …

Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children

E Aleebrahim-Dehkordi, F Soveyzi, N Deravi… - Journal of pediatric …, 2021 - Elsevier
The novel coronavirus, known as 2019-nCoV or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has caused an epidemic with high mortality and morbidity …

[HTML][HTML] A brief overview of SARS-CoV-2 infection and its management strategies: a recent update

A Das, S Pathak, M Premkumar… - Molecular and Cellular …, 2023 - Springer
The COVID-19 pandemic has become a global health crisis, inflicting substantial morbidity
and mortality worldwide. A diverse range of symptoms, including fever, cough, dyspnea, and …

[HTML][HTML] A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)

R Lotfi, RN Kalmarzi, SA Roghani - Immunologic research, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by a
newly identified coronavirus called the severe acute respiratory syndrome-coronavirus 2 …

Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19

A Araújo, G Sgorlon, LE Aguiar… - Experimental …, 2023 - journals.sagepub.com
The administration of vaccination doses to the global population has led to a decrease in the
incidence of COVID-19. However, the clinical picture developed by infected individuals …

Health care policies and COVID-19 prevalence: is there any association?

SA Nejadghaderi, A Saghazadeh… - International Journal of …, 2022 - journals.sagepub.com
The coronavirus disease 2019 (COVID-19) pandemic has affected almost all countries and
territories. As of December 6, 2020, the United States of America and India have the highest …

Introduction on coronavirus disease (COVID-19) pandemic: the global challenge

N Rezaei, S Ashkevarian, MK Fathi, S Hanaei… - … Disease-COVID-19, 2021 - Springer
By driving the ongoing pandemic of coronavirus disease 2019 (COVID-19), coronaviruses
have become a significant change in twenty-first-century medicine, healthcare systems …